Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.

BACKGROUND Deficits in social cognition and neurocognition are believed to underlie schizophrenia disability. Attempts at rehabilitation have had circumscribed effects on cognition, without concurrent improvement in broad aspects of behavior and adjustment. OBJECTIVE To determine the differential effects of cognitive enhancement therapy (a recovery-phase intervention) on cognition and behavior compared with state-of-the-art enriched supportive therapy. DESIGN A 2-year, randomized controlled trial with neuropsychological and behavioral assessments completed at baseline and at 12 and 24 months. SETTING An outpatient research clinic housed in a medical center's comprehensive care service for patients with severe mental illness. PATIENTS A total of 121 symptomatically stable, non-substance-abusing but cognitively disabled and chronically ill patients with schizophrenia or schizoaffective disorder. INTERVENTIONS Cognitive enhancement therapy is a multidimensional, developmental approach that integrates computer-assisted training in neurocognition with social cognitive group exercises. Enriched supportive therapy fosters illness management through applied coping strategies and education. MAIN OUTCOME MEASURES Six highly reliable summary measures--Processing Speed, Neurocognition, Cognitive Style, Social Cognition, Social Adjustment and Symptoms--were tested using analysis of covariance and linear trend analysis. RESULTS At 12 months, robust cognitive enhancement therapy effects were observed on the Neurocognition and Processing Speed composites (P<.003), with marginal effects observed on the behavioral composites. By 24 months, differential cognitive enhancement therapy effects were again observed for the 2 neuropsychological composites and for Cognitive Style (P=.001), Social Cognition (P=.001), and Social Adjustment (P=.01). As expected, no differences were observed on the residual Symptoms composite. Effects were unrelated to the type of antipsychotic medication received. Enriched supportive therapy also demonstrated statistically significant within-group effect sizes, suggesting that supportive psychotherapy can also have positive, although more modest, effects on cognitive deficits. CONCLUSION Many cognitive deficits and related behaviors of patients with stable schizophrenia are improved when sufficient exposure to relevant rehabilitation is provided.

[1]  P. Corrigan,et al.  Schizophrenic patients' sensitivity to social cues: the role of abstraction. , 1993, The American journal of psychiatry.

[2]  G. Hogarty,et al.  Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. , 1997, The American journal of psychiatry.

[3]  J. Cadet,et al.  Social Intelligence, a Neurological System? , 1989, Psychological reports.

[4]  Michael F. Green,et al.  What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.

[5]  H. Kraemer,et al.  Mediators and moderators of treatment effects in randomized clinical trials. , 2002, Archives of general psychiatry.

[6]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[7]  W. Tryon,et al.  Effectiveness of attention training in schizophrenia. , 1998, Schizophrenia bulletin.

[8]  J. Lieberman,et al.  The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. , 1999, Schizophrenia bulletin.

[9]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[10]  H. Kraemer.  To increase power in randomized clinical trials without increasing sample size. , 1991, Psychopharmacology bulletin.

[11]  Philip D. Harvey,et al.  Treatment of cognitive deficits in schizophrenia. , 2006, Current opinion in investigational drugs.

[12]  G. Hogarty,et al.  Drug and sociotherapy in the aftercare of schizophrenic patients. III. Adjustment of nonrelapsed patients. , 1974, Archives of general psychiatry.

[13]  J. Fleiss,et al.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. , 1976, Archives of general psychiatry.

[14]  Jane S. Paulsen,et al.  Generalized cognitive deficits in schizophrenia: a study of first-episode patients. , 1999, Archives of general psychiatry.

[15]  B. Everitt,et al.  The effects of neurocognitive remediation on executive processing in patients with schizophrenia. , 1999, Schizophrenia bulletin.

[16]  G. Hogarty,et al.  Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. , 1997, The American journal of psychiatry.

[17]  N C Andreasen,et al.  Symptoms of Schizophrenia: Methods, Meanings, and Mechanisms , 1995 .

[18]  J. McEvoy,et al.  Pharmacotherapy of impaired affect in recovering schizophrenic patients. , 1995, Archives of general psychiatry.

[19]  S. Silverstein,et al.  Shaping attention span: an operant conditioning procedure to improve neurocognition and functioning in schizophrenia. , 2001, Schizophrenia bulletin.

[20]  S. Silverstein.  Information processing, social cognition, and psychiatric rehabilitation in schizophrenia. , 1997, Psychiatry.

[21]  T. K. Srull,et al.  Handbook of Social Cognition , 1993 .

[22]  G. Hogarty,et al.  Practice principles of cognitive enhancement therapy for schizophrenia. , 1999, Schizophrenia bulletin.

[23]  P. Williamson,et al.  Neuropsychological correlates of syndromes in schizophrenia , 1997, British Journal of Psychiatry.

[24]  W. Carpenter,et al.  Domains of Psychopathology: An Approach to the Reduction of Heterogeneity in Schizophrenia , 1994, The Journal of nervous and mental disease.

[25]  P. Liddle.  Schizophrenic syndromes, cognitive performance and neurological dysfunction , 1987, Psychological Medicine.

[26]  G. Hogarty,et al.  Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates. , 1973, Archives of general psychiatry.

[27]  W. Spaulding,et al.  Effects of cognitive treatment in psychiatric rehabilitation. , 1999, Schizophrenia bulletin.

[28]  V. Reyna,et al.  Gist is the grist: Fuzzy-trace theory and the new intuitionism☆ , 1990 .

[29]  J. Barth,et al.  The Halstead-Reitan Neuropsychological Test Battery. , 2000 .

[30]  Michael F. Green,et al.  Normal neurocognitive performance after extended practice in patients with schizophrenia , 1997, Schizophrenia Research.

[31]  M. Keshavan,et al.  Brain maturational processes and delayed onset in schizophrenia , 1999, Development and Psychopathology.

[32]  Robert K. Heaton,et al.  Wisconsin Card Sorting Test Manual – Revised and Expanded , 1993 .

[33]  W. Spaulding,et al.  Applications of experimental psychopathology in psychiatric rehabilitation. , 1986, Schizophrenia bulletin.

[34]  D. Velligan,et al.  Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia. , 2000, The American journal of psychiatry.

[35]  B. Wexler,et al.  Neurocognitive enhancement therapy with work therapy: effects on neuropsychological test performance. , 2001, Archives of general psychiatry.

[36]  C. Correll,et al.  Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. , 2003, The American journal of psychiatry.

[37]  L. Mussgay,et al.  Reduction of schizophrenic deficits by cognitive training: An evaluative study , 2005, European archives of psychiatry and neurological sciences.

[38]  O. G. Jr. Brim,et al.  Socialization Through the Life Cycle , 1968 .

[39]  J. Lieberman,et al.  Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment. , 1997, Archives of general psychiatry.

[40]  N. Revheim,et al.  The remediation of problem-solving skills in schizophrenia. , 2001, Schizophrenia bulletin.

[41]  P. Berger,et al.  Social Construction of Reality , 1991, The SAGE International Encyclopedia of Mass Media and Society.

[42]  D. A. Johnson,et al.  The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences , 1983, Acta psychiatrica Scandinavica.

[43]  E. Walker,et al.  Intelligence in schizophrenia: meta-analysis of the research. , 1984, Schizophrenia bulletin.

[44]  M.P.A. Judith Jaeger Ph.D.,et al.  NEUROPSYCHIATRIC REHABILITATION FOR PERSISTENT MENTAL ILLNESS , 2004 .

[45]  J. Neale,et al.  The neuropsychological signature of schizophrenia: generalized or differential deficit? , 1994, The American journal of psychiatry.

[46]  J. Gold,et al.  Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies. , 1999, Schizophrenia bulletin.

[47]  G. Dunn,et al.  Cognitive deficit and the prediction of rehabilitation success in a chronic psychiatric group , 1992, Psychological Medicine.

[48]  T. White,et al.  Syndromes of Chronic Schizophrenia and Some Clinical Correlates , 1992, British Journal of Psychiatry.

[49]  R. Oades,et al.  Schizophrenia: Empirical Research and Findings , 1992 .

[50]  G. Hogarty,et al.  Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. I. One-year effects of a controlled study on relapse and expressed emotion. , 1986, Archives of general psychiatry.

[51]  R. Liberman,et al.  A controlled trial of cognitive remediation in schizophrenia. , 2002, Schizophrenia bulletin.

[52]  D. Greenberg.  Symptoms of Schizophrenia , 1994 .

[53]  L. Diller,et al.  Outcome of different treatment mixes in a multidimensional neuropsychological rehabilitation program. , 1992 .

[54]  D. Levy.  Psychopathology: Location, location, location: The pathway from behavior to brain locus in schizophrenia , 1996 .

[55]  K. Nuechterlein,et al.  Should schizophrenia be treated as a neurocognitive disorder? , 1999, European Neuropsychopharmacology.

[56]  J. Lieberman,et al.  Implications for the neural basis of social cognition for the study of schizophrenia. , 2003, The American journal of psychiatry.

[57]  M. Green,et al.  A training procedure for remediating WCST deficits in chronic psychotic patients: an adaptation of errorless learning principles. , 1996, Journal of psychiatric research.

[58]  Y. Ben-Yishay,et al.  Neuropsychologic Rehabilitation: Quest for a Holistic Approach , 1985 .

[59]  J. Wing.  A simple and reliable subclassification of chronic schizophrenia. , 1961, The Journal of mental science.

[60]  A. Raskin,et al.  REPLICATION OF FACTORS OF PSYCHOPATHOLOGY IN INTERVIEW, WARD BEHAVIOR AND SELF‐REPORT RATINGS OF HOSPITALIZED DEPRESSIVES , 1969, The Journal of nervous and mental disease.

[61]  C. Cohen.  Overcoming social amnesia: the role for a social perspective in psychiatric research and practice. , 2000, Psychiatric services.

[62]  J. McEvoy,et al.  Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia. Results of a two-year controlled study. , 1988, Archives of general psychiatry.

[63]  R. Reitan,et al.  3/The Halstead-Reitan Neuropsychological Test Battery and Aging , 1986 .

[64]  McEvoy Jp.  Expert Consensus Guideline Series Treatment of Schizophrenia 1999 , 1999 .

[65]  T. Wykes,et al.  The Prediction of Rehabilitative Success after Three Years the use of Social, Symptom and Cognitive Variables , 1990, British Journal of Psychiatry.

[66]  B. Rund,et al.  A review of longitudinal studies of cognitive functions in schizophrenia patients. , 1998, Schizophrenia bulletin.

[67]  K H Nuechterlein,et al.  Effects of attention training on information processing in schizophrenia. , 1994, Schizophrenia bulletin.

[68]  G. Hogarty,et al.  Developmental theory for a cognitive enhancement therapy of schizophrenia. , 1999, Schizophrenia bulletin.

[69]  H E ROSVOLD,et al.  A continuous performance test of brain damage. , 1956, Journal of consulting psychology.

[70]  G. Hogarty.  Personal Therapy for Schizophrenia and Related Disorders: A Guide to Individualized Treatment , 2002 .

[71]  G. Hogarty,et al.  Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates. , 1974, Archives of general psychiatry.

[72]  P. Knapp,et al.  Effects of psychotherapy in schizophrenia: II. Comparative outcome of two forms of treatment. , 1984, Schizophrenia bulletin.

[73]  G. Hogarty,et al.  Temporal effects of drug and placebo in delaying relapse in schizophrenic outpatients. , 1977, Archives of general psychiatry.

[74]  S. Lawrie,et al.  Errorless learning and the cognitive rehabilitation of memory-impaired schizophrenic patients , 1999, Psychological Medicine.

[75]  D. Jeste,et al.  Stability and course of neuropsychological deficits in schizophrenia. , 2001, Archives of general psychiatry.

[76]  R. Heaton,et al.  Neuropsychological test results associated with psychiatric disorders in adults. , 1978, Psychological bulletin.

[77]  J. T. Marsh,et al.  Information-processing deficits across childhood- and adult-onset schizophrenia. , 1994, Schizophrenia bulletin.

[78]  M. Hannan,et al.  Estimation in Panel Models: Results in Pooling Cross-Sections and Time Series , 1977 .

[79]  P F Liddle,et al.  Schizophrenic Syndromes and Frontal Lobe Performance , 1991, British Journal of Psychiatry.

[80]  D. Braff,et al.  Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? , 2000, Schizophrenia bulletin.

[81]  W. Spaulding,et al.  Cognitive functioning in schizophrenia: implications for psychiatric rehabilitation. , 1999, Schizophrenia bulletin.